Literature DB >> 10485339

Effects of phosphatidylinositol 4,5-bisphosphate and neomycin on phospholipase D: kinetic studies.

Y Huang1, I A Qureshi, H Chen.   

Abstract

The kinetics of phosphatidylcholine-specific phospholipase D activated by phosphatidylinositol 4,5-bisphosphate (PIP2) and inhibition by neomycin were studied in an enzyme preparation partially purified from human hepatocarcinoma cell line. It was found that phospholipase D was marginally activated by phosphatidyl-4-phosphate (PIP) and phosphatidylethanolamine (PE). In contrast, it was considerably activated by PIP2 in different concentration of phosphatidylcholine (PC). Sphingomyelin (SM), lysophosphatidylcholine (LPC) and phosphatidylserine (PS) were neither substrates nor inhibitors of the phospholipase D. PIP, induced an allosteric effect on phospholipase D and a negative cooperative effect with respect to phosphatidylcholine as indicated in the Lineweaver-Burk plot. In the absence of PIP2, a straight line was obtained, whereas a downward concave curve was observed in the presence of 25 microM of PIP2. The Hill coefficient and the apparent K(m) of phosphatidylcholine in the presence of 25 microM PIP, were calculated to be 0.631 and 10.79 mM, respectively. PIP2 also increased the maximal velocity (Vmax) of the phospholipase D reaction, suggesting that the affinity of substrate to enzyme was decreased, and the turnover number of the enzyme (kcat) was increased by PIP2. The activation of phospholipase D by PIP2 was dose dependent up to 50 microM of PIP2. The Ka of PIP2 was 15.8 mM. Neomycin, a polycationic glycoside, was shown to be an uncompetitive inhibitor of phospholipase D, and revealed the formation of a neomycin-PIP2 complex. The Ki of neomycin was estimated to be 8.7 mM.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10485339     DOI: 10.1023/a:1006930706311

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  29 in total

1.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

Review 2.  The regulation and cellular functions of phosphatidylcholine hydrolysis.

Authors:  M M Billah; J C Anthes
Journal:  Biochem J       Date:  1990-07-15       Impact factor: 3.857

3.  Resolved phospholipase D activity is modulated by cytosolic factors other than Arf.

Authors:  W D Singer; H A Brown; G M Bokoch; P C Sternweis
Journal:  J Biol Chem       Date:  1995-06-23       Impact factor: 5.157

Review 4.  Phospholipid signaling.

Authors:  N Divecha; R F Irvine
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

5.  Binding of neomycin to phosphatidylinositol 4,5-bisphosphate (PIP2).

Authors:  E Gabev; J Kasianowicz; T Abbott; S McLaughlin
Journal:  Biochim Biophys Acta       Date:  1989-02-13

6.  Involvement of Ral GTPase in v-Src-induced phospholipase D activation.

Authors:  H Jiang; J Q Luo; T Urano; P Frankel; Z Lu; D A Foster; L A Feig
Journal:  Nature       Date:  1995-11-23       Impact factor: 49.962

7.  Insulin-stimulated hydrolysis of phosphatidylcholine by phospholipase C and phospholipase D in cultured rat hepatocytes.

Authors:  V Donchenko; A Zannetti; P M Baldini
Journal:  Biochim Biophys Acta       Date:  1994-07-21

Review 8.  Choline phospholipids: signal transduction and carcinogenesis.

Authors:  S H Zeisel
Journal:  FASEB J       Date:  1993-04-01       Impact factor: 5.191

9.  ADP-ribosylation factor, a small GTP-dependent regulatory protein, stimulates phospholipase D activity.

Authors:  H A Brown; S Gutowski; C R Moomaw; C Slaughter; P C Sternweis
Journal:  Cell       Date:  1993-12-17       Impact factor: 41.582

Review 10.  Lipid mediators and protein kinase C activation for the intracellular signaling network.

Authors:  S Nakamura; Y Nishizuka
Journal:  J Biochem       Date:  1994-06       Impact factor: 3.387

View more
  6 in total

1.  Regulation of phospholipase D from human hepatocarcinoma cell line by purine nucleotides and protein kinase A.

Authors:  Y Huang; X Y Zhang; F Liu; H L Chen
Journal:  Mol Cell Biochem       Date:  2000-04       Impact factor: 3.396

2.  Akt phosphorylation of merlin enhances its binding to phosphatidylinositols and inhibits the tumor-suppressive activities of merlin.

Authors:  Masashi Okada; Yanru Wang; Sung-Wuk Jang; Xiaoling Tang; Luca M Neri; Keqiang Ye
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

Review 3.  Tyrosyl-DNA phosphodiesterase as a target for anticancer therapy.

Authors:  Thomas S Dexheimer; Smitha Antony; Christophe Marchand; Yves Pommier
Journal:  Anticancer Agents Med Chem       Date:  2008-05       Impact factor: 2.505

4.  5-Fluoro-2-indolyl des-chlorohalopemide (FIPI), a phospholipase D pharmacological inhibitor that alters cell spreading and inhibits chemotaxis.

Authors:  Wenjuan Su; Oladapo Yeku; Srinivas Olepu; Alyssa Genna; Jae-Sook Park; Hongmei Ren; Guangwei Du; Michael H Gelb; Andrew J Morris; Michael A Frohman
Journal:  Mol Pharmacol       Date:  2008-12-08       Impact factor: 4.436

5.  Promising New Inhibitors of Tyrosyl-DNA Phosphodiesterase I (Tdp 1) Combining 4-Arylcoumarin and Monoterpenoid Moieties as Components of Complex Antitumor Therapy.

Authors:  Tatyana M Khomenko; Alexandra L Zakharenko; Arina A Chepanova; Ekaterina S Ilina; Olga D Zakharova; Vasily I Kaledin; Valeriy P Nikolin; Nelly A Popova; Dina V Korchagina; Jóhannes Reynisson; Raina Chand; Daniel M Ayine-Tora; Jinal Patel; Ivanhoe K H Leung; Konstantin P Volcho; Nariman F Salakhutdinov; Olga I Lavrik
Journal:  Int J Mol Sci       Date:  2019-12-23       Impact factor: 5.923

6.  WNT Activates the AAK1 Kinase to Promote Clathrin-Mediated Endocytosis of LRP6 and Establish a Negative Feedback Loop.

Authors:  Megan J Agajanian; Matthew P Walker; Alison D Axtman; Roberta R Ruela-de-Sousa; D Stephen Serafin; Alex D Rabinowitz; David M Graham; Meagan B Ryan; Tigist Tamir; Yuko Nakamichi; Melissa V Gammons; James M Bennett; Rafael M Couñago; David H Drewry; Jonathan M Elkins; Carina Gileadi; Opher Gileadi; Paulo H Godoi; Nirav Kapadia; Susanne Müller; André S Santiago; Fiona J Sorrell; Carrow I Wells; Oleg Fedorov; Timothy M Willson; William J Zuercher; Michael B Major
Journal:  Cell Rep       Date:  2019-01-02       Impact factor: 9.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.